ADARx Pharmaceuticals (ADRX)
ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseas...
- Open
- 19.900
- High
- 21.500
- Low
- 19.510
- Prev. Close
- 20.090
- Volume
- 1.30M
- Turnover
- 26.81M
- Avg Price
- 20.632
- Bid/Ask Ratio
- 96.08%
- Amplitude
- 9.91%
- 52wk High
- 23.210
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.41%
- 52wk Low
- 18.500
- Float Mkt Cap
- 1.91B
- Market CapUSD
- 2.20B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.824
- EPSDynamic
- -0.909
- EPSStatic
- --
- BVPS
- -2.36
- P/B
- --
- Circulating Supply
- 92.34M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 106.58M
- Min lot size
- 1
- Currency
- USD
